Osmotic nephrosis due to high-dose immunoglobulin therapy containing sucrose (but not with glycine) in a patient with immunoglobulin A nephritis

American Journal of Kidney Diseases

Volumn 28, Issue 3, 1996, Pages 451-453

  Hansen Schmidt, Stefan ^a   Silomon, Jörg ^a   Keller, Frieder ^a  

^a UNIVERSITY HOSPITAL ULM   (Germany)

Author keywords

Acute renal failure; glycine; immunoglobulin; immunoglobulin A nephritis; osmotic nephrosis; sucrose; vacuolization

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; FELODIPINE; GLYCINE; IMMUNOGLOBULIN; IMMUNOGLOBULIN 7S; RANITIDINE; SUCROSE;

ACUTE KIDNEY FAILURE; ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; GASTRITIS; HEMODIALYSIS; HUMAN; HUMAN TISSUE; HYPERTENSION; IMMUNOGLOBULIN A NEPHROPATHY; IMMUNOHISTOLOGY; IMMUNOTHERAPY; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY BIOPSY; LABORATORY TEST; MALE; NEPHROSIS;

EID: 0029809027     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0272-6386(96)90505-3     Document Type: Article

References (18)

1. Dwyer JM: Manipulating the immune system with immune globulin. N Engl J Med 326:107-119, 1992
2. Rostoker G, Desvaux-Belgiti D, Pilatte Y, Petit-Phar M, Phillipon C, Deforges L, Terzidis H, Intrator L, André C, Adnot S, Bonin P, Bierling P, Rémy P, Lagrue G, Lang P, Weil B: High-dose immunoglobulin therapy for severe IgA nephropathy and Henoch-Schönlein purpura. Ann Intern Med 120:476-484, 1994
3. Cantú TG, Hoehn-Saric EW, Burgess KM, Racusen L, Scheel PJ: Acute renal failure associated with immunoglobulin therapy. Am J Kidney Dis 25:228-234, 1995
4. Steward RRC, Winney RJ, Cash JD: Renal toxicity of intravenous immunoglobulin. Vox Sang 65:244, 1993 (letter)
5. Pirner K, Rubbert A, Burmester GR, Kalden JR, Manger B: Intravenös verabreichte Immunglobuline beim systemischen Lupus erythematodes: Literaturübersicht und erste klinische Erfahrungen. Infusionsther Transfusionsmed 20: 131-136, 1993 (suppl 1)
6. Jordan SC: Intravenous gamma-globulin therapy in systemic lupus erythematodes and immune complex disease. Clin Immunol Immunopathol 53:164-169, 1989
7. Corvetta A, Della Britta R, Gabrielli A, Spaeth PJ, Daniel G: Use of high dose intravenous immunoglobulin in systemic lupus erythematosus: Report of three cases. Clin Exp Rheumatol 7:295-299, 1989
8. Reinhart WH, Berchtold PE: Effect of high-dose intravenous immunoglobulin therapy on blood rheology. Lancet 339:662-664, 1992
9. Anderson AD, Bethea WR: Renal lesions following administration of hypertonic solutions of sucrose. JAMA 114:1983-1987, 1940
10. Dorman HR, Sondheimer JH, Cadnapaphorchai P: Mannitol-induced acute renal failure. Medicine 69:153-159, 1990
11. Morgan TO, Little JM, Evans WA: Renal failure associated with low-molecular weight dextran infusion. BMJ 2:737-739, 1966
12. Berns AS: Nephrotoxicity of contrast media. Kidney Int 36:730-740, 1989
13. Vettorazzi G, Macdonald I: Sucrose Nutritional and Safety Aspects. Heidelberg, Germany, Springer, 1988, pp 35-36
14. Schuster H, Gerstmayer A, Scheller F, Strauss D: Zur Elimination von Saccharose aus dem Blut und ihrer renalen Ausscheidung nach Transfusion buffy coat-freier, disaccharidhaltiger Erythrozyten-konzentrate. Folia Haematol Int 114:895-902, 1987
15. Merski JA, Meyers MC: Light- and electron-microscopic evaluation of renal tubular cell vacuolation induced by administration of nitrilotriacetate or sucrose. Food Chem Toxicol 23:923-930, 1985
16. Morris RC, Harlan EI: Inherited disorders of the renal tube, in Brenner BM (ed): Brenner and Rector's The Kidney (ed 5), vol 2. Philadelphia, PA, Saunders, 1996, pp 1769-1770
17. Miller GW, Lock EA, Schnellmann RG: Strychnine and glycine protect renal proximal tubules from various nephrotoxicants and act in the late phase of necrotic cell injury. Toxicol Appl Pharmacol 125:192-197, 1994
18. Weinberg JM: The cell biology of ischemic renal injury. Kidney Int 39:476-500, 1991